Analysis shows rising morbidity and mortality trends in malignant neoplasms in the Siberian Federal District, highlighting the need for improved cancer care.
Key Points
Morbidity from malignant neoplasms in the Siberian Federal District increased by 13.9% between 2012 and 2022, indicating a concerning trend.
The forecast predicts a 10.7% increase in crude morbidity by 2030, emphasizing the need for effective cancer management strategies.
Statistical analysis utilized standard methods, assessing mortality and morbidity rates with a significant confidence level of p<0.05.
Calls for enhanced public awareness and preventive measures to improve cancer care, given the dependency of mortality on morbidity levels.